US market to dent India pharma earnings even as domestic growth remains firm
New Delhi: India’s pharmaceutical sector is likely to witness steady domestic growth but continued pressure in the US market in the fourth quarter of FY26, according to a report by…
Indian Pharma Market grows by 7.9% in July; antibiotic Augmentin rebounds to top spot
New Delhi: The Indian Pharmaceutical Market (IPM) in July underwent a value growth of 7.9 per cent driven by new launches in the anti-diabetic segment and value growth of cardiac…
Indian Pharma Market Reaches Rs 19,083 Crore In December, Check Out Top Performing Brands
New Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This marks a 7.68% increase compared to the previous…









